Generic Armod Price List - US & International Markets

First look at the top tieric and Basics

Armodafinil, commonly referred to as armod, is a prescription wakefulness-promoting medication. It is the single-enantiomer formulation of modafinil and belongs to a class often called eugeroics. The medicine is prescribed for adults to help manage excessive daytime sleepiness linked to defined sleep disorders and is not a substitute for regular, adequate sleep.

A brief an executive summary of the critical facts:

• Active molecule: armodafinil
• Main purpose: reduce excessive daytime sleepiness (EDS)
• Typical tablet strengths available in the United States: commonly 50 mg and 150 mg
• Related sections on this page: pharmacokinetic and pharmacodynamic two-way communication in actions in the user journey shape satisfaction. between drugs, other treatment strategies, cost structure, and legal factors to evaluate

Uses and Markers of change: A Quick Guide

Clinicians prescribe armodafinil to improve wakefulness in adults with certain diagnosed sleep disorders. Principal approved uses include:

• The narcolepsy condition where daytime sleepiness is a prominent symptom
• Residual sleepiness in patients with obstructive sleep apnea (OSA) despite primary OSA therapy
• Shift work sleep disorder (SWD) to promote alertness during work shifts

Some clinicians prescribe armodafinil for off-label reasons such as refractory fatigue or select attention disorders, but such uses vary by clinician judgment and supporting evidence. For rules about prescribing and legal limits, see Statutory status and regulatory guidelines.

Dose Information and Directions

Follow the exact instructions your prescriber gives. Typical adult dosing patterns include the following examples:

• For narcolepsy or OSA-related sleepiness: usually taken once each morning; a common initial dose is 150 mg daily.
• For shift work sleep disorder: often taken about one hour before the start of the work shift; 150 mg is a frequently used dose.

Some prescribers start with a lower amount, for example 50 mg, to check how well the medication is tolerated. Taking armodafinil later in the day can interfere with nighttime sleep. It may be taken with or without food, although a heavy meal can delay its onset.

Questions about timing, prescribed dose was misseds, or tracking collaborative interactions helps measure engagement. can be resolved in the Dose has not been administered and Drug Interaction Management sections below.

Steps to prevent harm and Safety Protocols

Prior to starting armodafinil, discuss your full medical history with the prescriber, especially if any of the following apply:

• Operating vehicles or heavy machinery: do not drive or operate dangerous equipment until you know how the drug affects you. Short term effects such as dizziness and visual changes have been reported.
• Mental health concerns: mood swings, increased anxiety, agitation, or worsening depression may occur. Report new or changing psychiatric symptoms promptly.
• Cardiovascular issues: armodafinil can increase heart rate and blood pressure. People with heart disease, arrhythmias, or uncontrolled hypertension require careful evaluation and constant monitoring.
• Pregnancy and lactation: use only when the expected benefit justifies potential risk; discuss family planning and breastfeeding in coordination with your clinician.
• Concurrent alcohol or stimulant use: combining substances may increase detrimental outcomes; use caution and seek advice.
• Reduced hepatic function and older adults: dosing adjustments or additional monitoring in real time may be needed for hepatic dysfunction and age-related sensitivity.

Reasons to avoid use and Serious Alerts

• Known hypersensitivity to armodafinil, modafinil, or any component of the formulation.
• History of significant cardiac events or reactions to stimulants that suggest increased risk with armodafinil.

Severe skin reactions, including Stevens-Johnson syndrome or toxic epidermal necrolysis, have occurred with related agents. If you develop a widespread rash, blisters, mouth ulcers, facial swelling, or fever, discontinue the medication and seek immediate medical care.

Reactions to the medicine

Commonly reported adverse impact on health include:

• Migraine
• Nausea or other gastric upset
• Lightheadedness
• Hard time falling asleep
• Anxiety, nervousness, or jittery feeling

Seek urgent help if you experience chest pain, very high blood pressure, severe mood changes, hallucinations, suicidal thoughts, or signs of a serious allergic reaction. See An overdose death of medicine and Emergent Medical Situation for emergency expert counsel.

Interactions Between Medications

Armodafinil affects several liver enzymes and can interact with other medicines. Major interplays include:

• Drugs that inhibit CYP3A4, for example ketoconazole or itraconazole, may raise armodafinil levels.
• Armodafinil can induce CYP3A4 and reduce the effectiveness of hormonal contraceptives that contain ethinyl estradiol and norethindrone. Use a reliable nonhormonal backup method during treatment and for at least one month after stopping.
• Effects on CYP2C19 may increase levels of drugs such as diazepam, omeprazole, propranolol, and phenytoin, so status monitoring or dose adjustment could be needed.
• Other reported interactions create opportunities for collaboration. include reduced cyclosporine exposure and growth potential effects on warfarin and some antiseizure medicines; clinical keeping track of metrics is advisable.

Always give your clinician and pharmacist a complete list of prescription drugs, over-the-counter products, and supplements before beginning armodafinil. For dosing matters review the Recommended Dosage and Instructions section.

Medication dose was not taken Protocol

If you forget a scheduled dose, take it when you remember unless it is near the time for your next scheduled dose. If it is late in the day, skip the a dose was missed to avoid insomnia. Do not exceed the prescribed dose to compensate for a a dose was missed.

For regular dosing patterns and timing details, refer back to Suggested Amount and Directions.

Overdose risk and Acute Emergency Procedures

Symptoms of overdosed may include agitation, restlessness, confusion, hallucinations, tremor, palpitations, nausea, and diarrhea. If you suspect an overdosed, call 911 or contact the US Poison Control Center at 1-800-222-1222 immediately.

Encrypted cold storage is used for long term preservation of rare items. and Handling Guidelines

• Store at normal room temperature, about 20 to 25 C (68 to 77 F).
• Protect tablets from excessive moisture and direct sunlight.
• Keep medications secured and out of reach of children and pets, preferably in a child-resistant container.

A Survey of Alternative options and Comparisons

When armodafinil is not appropriate or tolerated, several other therapies may be considered. Below are commonly compared options with short contrasts:

• Modafinil (racemic mixture): used for the same primary manifestations as armodafinil. Effectiveness is similar; some patients note differences in onset or duration of effect. Both are Schedule IV in the US.
• Solriamfetol (Sunosi): a dopamine and norepinephrine reuptake inhibitor approved for EDS in OSA and narcolepsy. It can increase blood pressure and heart rate; it is also a controlled substance.
• Pitolisant (Wakix): a histamine H3 receptor antagonist/inverse agonist indicated for narcolepsy. In the US it is not a controlled substance and may have distinct benefits for cataplexy in some patients.
• CNS stimulants (for example methylphenidate, amphetamine salts): sometimes used for resistant daytime sleepiness but carry higher abuse potential and are Schedule II drugs with stricter prescribing rules.
• Nonpharmacologic measures: ensure optimal CPAP treatment for OSA, use light therapy, scheduled short naps, and reinforce sleep hygiene as part of a comprehensive plan.

Clinical suitability, insurance coverage, and out-of-pocket cost differ across these choices. See Price Forecasts in USD and Legal position within the regulatory landscape for added context.

Estimated Prices in the United States wholesale pricing in USD

Retail costs vary by pharmacy, dose, brand versus generic, conjoined with the availability of discounts or manufacturer assistance. The ranges below are rough estimates and not price guarantees.

• Generic armodafinil (50 mg or 150 mg): with discount programs commonly about $0.80 to $3.00 per tablet; a 30-tablet supply without discounts can run roughly $150 to $350.
• Brand armodafinil (for example Nuvigil): retail prices often fall in the $10 to $20 per tablet range; monthly retail cost may reach $600 to $900 without savings.
• Generic modafinil: approximate coupon prices $1 to $4 per tablet; historical brand Provigil value based pricing often approached $600 to $1,000 per 30 tablets.
• Solriamfetol (Sunosi): typical list or retail cost for a 30-day supply often ranges from $700 to $900.
• Pitolisant (Wakix): list prices can be several thousand dollars per month; manufacturer assistance programs may lower patient expenses.
• Generic stimulant medications: wide variability by formulation; some generics may cost $10 to $60 per month, with branded extended-release products costing more.

To find current local billing rates check nearby pharmacies, online prices in a side by side comparison tools, insurer pharmacy benefits, and manufacturer savings programs. Coupons and discount pharmacies can substantially reduce out-of-pocket costs for eligible patients.

Legal condition in the United States and Regulation Birds eye view

Key legal points to be aware of:

• Controlled substance classification: armodafinil is a Schedule IV controlled substance under federal law.
• Prescription requirement: you must have a valid prescription to obtain armodafinil. Federal rules typically allow up to five refills within six months for Schedule IV medications unless state law sets stricter limits.
• Electronic prescribing and telemedicine: e-prescriptions are commonly used for armodafinil. Telemedicine and DEA policies may change; verify current federal and state rules before relying on remote prescribing.
• Importation cautions issued: bringing controlled substances into the United States without DEA authorization is generally prohibited. Use licensed US pharmacies and test the system credentials such as NABP accreditation when ordering online.
• Employment and safety-sensitive positions: employers may have policies regarding controlled stimulant use in safety-sensitive jobs; inform occupational health when required.
• Off-label use and marketing: clinicians may prescribe off-label when clinically appropriate, but manufacturers are prohibited from marketing for unapproved clues.
• Sports and doping rules: stimulants including modafinil and related agents are often banned by sports authorities. Athletes should consult relevant governing bodies about Therapeutic Use Exemptions.

Because state laws, insurance policies, and pharmacy practices differ, confirm current legal and regulatory governance details with your prescriber, pharmacist, or legal advisor.